Get started
Author

Takeshi Suto

Observed names: Suto, Takeshi, T. Suto, TAKESHI SUTO, Takeshi SUTO
Observed institutions: Yamagata University, Plastic Surgery Hospital, Kitasato University Hospital, Yamagata Prefectural Central Hospital, Eisai (Japan), Kitasato University
ORCID: 0000-0002-2749-4819
Observed ORCID: 0000-0002-2749-4819
OpenAlex ID: A5103159896
Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review
2013 · Hideki Ueno, Kazuo Hase, et al. · Journal of Gastroenterology · 134
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study
2017 · Toshikazu Moriwaki, Shota Fukuoka, et al. · The Oncologist · 108
PDF
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
2020 · Toshiki Masuishi, Akihito Tsuji, et al. · British Journal of Cancer · 53
PDF
The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation
2017 · Takeshi Suto, Masahiko Watanabe, et al. · Journal of Gastrointestinal Surgery · 46
PDF
A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: JCOG0603 study.
2020 · Yukihide Kanemitsu, Yasuhiro Shimizu, et al. · Journal of Clinical Oncology · 32
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603
2026 · Yukihide Kanemitsu, Yasuhiro Shimizu, et al. · Journal of Clinical Oncology · 26
PDF
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer
2018 · Kenji Tsuchihashi, Mamoru Ito, et al. · Clinical Colorectal Cancer · 22
Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801)
2014 · Hiroshi Soeda, Hideki Shimodaira, et al. · Oncology · 21
Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm
2021 · Tatsuro Yamaguchi, Kohei Murata, et al. · Digestive Surgery · 20
Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study
2022 · Ryo Seishima, Koji Okabayashi, et al. · The American Journal of Gastroenterology · 19
Phase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial
2018 · H. Osawa, E. Shinozaki, et al. · Annals of Oncology · 19
Multiple carcinoid tumors of the rectum: Report of two cases suggesting the origin of carcinoid tumors
2012 · Shunichi Sasou, Takeshi Suto, et al. · Pathology International · 18
A multicenter cohort study on mapping of lymph node metastasis for splenic flexural colon cancer
2022 · Jun Watanabe, Yukihide Kanemitsu, et al. · Annals of Gastroenterological Surgery · 17
PDF
Long-term Outcome After Surgical Resection of Para-aortic Lymph Node Metastasis of Colorectal Cancer: A Multicenter Retrospective Study
2024 · Sono Ito, Yusuke Kinugasa, et al. · Diseases of the Colon & Rectum · 16
Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study
2021 · Hiroshi Takeyama, Kohei Murata, et al. · Journal of Gastrointestinal Surgery · 14
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study
2019 · Toshikazu Moriwaki, Shota Fukuoka, et al. · International Journal of Clinical Oncology · 14
MR Imaging of Uterine Epithelioid Trophoblastic Tumor: A Case Report
2016 · Sakiko KAGEYAMA, Masafumi KANOTO, et al. · Magnetic Resonance in Medical Sciences · 14
PDF
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
2020 · Akira Ooki, Satoshi Morita, et al. · Cancer Medicine · 13
PDF
Liquid biopsy for optimizing the rechallenge of cetuximab in metastatic colorectal cancer: Additional study of E-Rechallenge Trial.
2019 · Yoshihito Ohhara, Eiji Shinozaki, et al. · Journal of Clinical Oncology · 13
Diagnostic Accuracy of Imaging in Assessing Nonviability of Disappearing Colorectal Liver Metastasis
2025 · Kozo Kataoka, Murielle Mauer, et al. · JAMA Surgery · 12
PDF
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer
2017 · Takeshi Suto, Megumi Ishiguro, et al. · International Journal of Clinical Oncology · 12
PDF
Management of inguinal lymph node metastases from rectal and anal canal adenocarcinoma
2022 · Harunobu Sato, Kotaro Maeda, et al. · Colorectal Disease · 11
Efficacy and Safety of Low-Molecular-Weight Heparin on Prevention of Venous Thromboembolism after Laparoscopic Operation for Gastrointestinal Malignancy in Japanese Patients: A Multicenter, Open-Label, Prospective, Randomized Controlled Trial
2020 · Tamotsu Obitsu, Naoki Tanaka, et al. · Journal of the American College of Surgeons · 11
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)
2025 · Hiroya Taniguchi, Kay Uehara, et al. · Cancers · 10
PDF
Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum
2019 · Dai Shida, Hirotoshi Kobayashi, et al. · International Journal of Clinical Oncology · 10
Works count: 102
Citation count: 825
H-index: 14
I10-index: 25
Year
Topic
Type